Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. (Q46691360)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

title

Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1 reference

Jessica Koenigsknecht-Talboo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

Gary E Landreth

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

issue

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

8240-8249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

Other functions, other genes: alternative activation of antigen-presenting cells

6 January 2020

cites work

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease

1 reference

12 December 2020

Prostanoid receptors: structures, properties, and functions

1 reference

12 December 2020

The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex.

1 reference

12 December 2020

Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation.

1 reference

12 December 2020

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

12 December 2020

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

1 reference

12 December 2020

Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines

1 reference

12 December 2020

Inflammation and Alzheimer's disease

1 reference

12 December 2020

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

1 reference

12 December 2020

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

12 December 2020

NF-kappaB: a key role in inflammatory diseases

1 reference

12 December 2020

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

12 December 2020

beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

1 reference

12 December 2020

Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease.

1 reference

12 December 2020

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

1 reference

12 December 2020

3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid

1 reference

12 December 2020

Immunological aspects of alzheimer's disease: therapeutic implications.

1 reference

12 December 2020

Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse

1 reference

12 December 2020

Cyclooxygenase-independent actions of cyclooxygenase inhibitors

1 reference

12 December 2020

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

12 December 2020

Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.

1 reference

12 December 2020

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

12 December 2020

Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

1 reference

12 December 2020

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

1 reference

12 December 2020

CD40-CD40L interaction in Alzheimer's disease.

1 reference

12 December 2020

Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages

1 reference

12 December 2020

Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

1 reference

12 December 2020

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

1 reference

12 December 2020

Alternative activation of macrophages

1 reference

12 December 2020

The inflammatory macrophage: a story of Jekyll and Hyde

1 reference

12 December 2020

Adult mouse astrocytes degrade amyloid-beta in vitro and in situ

1 reference

12 December 2020

A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

1 reference

12 December 2020

Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation

1 reference

12 December 2020

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease

1 reference

12 December 2020

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

12 December 2020

The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of kappa B kinase, and NF kappa B, do not reduce amyloid beta 42 production

1 reference

12 December 2020

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

1 reference

12 December 2020

Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.

1 reference

12 December 2020

Novel regulatory mechanisms of CD40-induced prostanoid synthesis by IL-4 and IL-10 in human monocytes

1 reference

12 December 2020

Clearing amyloid through the blood-brain barrier

1 reference

12 December 2020

Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia.

1 reference

12 December 2020

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides

1 reference

12 December 2020

Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP.

1 reference

12 December 2020

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

1 reference

12 December 2020

Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.

1 reference

12 December 2020

Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging

1 reference

12 December 2020

Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD

1 reference

12 December 2020

CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.

1 reference

12 December 2020

Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor.

1 reference

12 December 2020

An immortalized cell line expresses properties of activated microglial cells

1 reference

12 December 2020

Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity

1 reference

12 December 2020

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

1 reference

12 December 2020

Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production

1 reference

12 December 2020

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs

1 reference

12 December 2020

Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus

1 reference

12 December 2020

Prostaglandin-mediated suppression of macrophage phagocytosis of Listeria monocytogenes

1 reference

12 December 2020

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

12 December 2020

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

12 December 2020

Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes.

1 reference

12 December 2020

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

12 December 2020

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

12 December 2020

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

12 December 2020

Molecular mechanisms of microglial activation

1 reference

12 December 2020

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia.

1 reference

12 December 2020

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

12 December 2020

Identification of monocyte chemoattractant protein‐1 in senile plaques and reactive microglia of Alzheimer's disease

1 reference

12 December 2020

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

12 December 2020

PPAR-γ agonists inhibit production of monocyte inflammatory cytokines

1 reference

12 December 2020

Regulation of macrophage phagocytosis of apoptotic cells by cAMP

1 reference

12 December 2020

Mechanism of action of antiinflammatory drugs

1 reference

12 December 2020

Cyclooxygenases 1 and 2

1 reference

12 December 2020

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

1 reference

12 December 2020

Pharmacological analysis of cyclooxygenase-1 in inflammation

1 reference

12 December 2020

Alzheimer's beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia

1 reference

12 December 2020

Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases

1 reference

12 December 2020

Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins

1 reference

12 December 2020

Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains

1 reference

12 December 2020

10.1523/JNEUROSCI.1808-05.2005

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16148231 AND SRC:MED&resulttype=core&format=json

6 January 2020

PubMed publication ID

16148231

1 reference